1-3 of 3
Mugdha Velankar, M.S
Close
Sort by
Journal Articles

Distinct Dynamic Profiles for NPI-0052-And Bortezomib-Induced Apoptosis in Multiple Myeloma.

Dharminder Chauhan, PhD, Ajita Singh, Ph.D, Mugdha Velankar, M.S, Teru Hideshima, Ph.D, Huib Ovaa, Ph.D, Celia Berkers, M.S, Giada Bianchi, Ph.D, Roberto Sitia, M.D., Nikhil C. Munshi, M.D., Paul Richardson, M.D., Michael A. Palladino, Ph.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2006) 108 (11): 3396.
https://doi.org/10.1182/blood.V108.11.3396.3396
Published: 2006
Journal Articles

Requirement of Caspase-8 Versus Caspase-9 during Apoptosis in Multiple Myeloma Cells Induced by Bortezomib- or a Novel Proteasome Inhibitor NPI-0052.

Dharminder Chauhan, PhD, Laurence Catley, M.D, Mugdha Velankar, M.S, Anthony Letai, M.D, Teru Hideshima, Ph.D, Klaus Podar, M.D, Hiroshi Yasui, M.D, Nicholas Mitsiades, M.D, Constantine Mitsiades, M.D, Yu-Tzu Tai, Ph.D, Noopur Raje, M.D, Nikhil Munshi, M.D, Michael A. Palladino, Ph.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2005) 106 (11): 3378.
https://doi.org/10.1182/blood.V106.11.3378.3378
Published: 2005
Journal Articles

Targeting Bcl-2 as Therapy for Multiple Myeloma.

Dharminder Chauhan, PhD, Mugdha Velankar, M.S, Teru Hideshima, Ph.D, Constantine Mitsiades, Ph.D, Laurence Catley, M.D, Noopur Raje, M.D, Robert Schlossman, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D.
Journal: Blood
Blood (2005) 106 (11): 109.
https://doi.org/10.1182/blood.V106.11.109.109
Published: 2005